American College of Radiology Appropriateness Criteria® on Conservative Surgery and Radiation: Stages I and II Breast Carcinoma

Journal of the American College of Radiology

Volumn 5, Issue 6, 2008, Pages 701-713

  White, Julia R ^a   Halberg, Francine E ^b   Rabinovitch, Rachel ^c   Green, Sheryl ^d   Haffty, Bruce G ^e   Solin, Lawrence J ^f   Strom, Eric A ^g   Taylor, Marie E ^h   Edge, Stephen B ⁱ  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Marin Cancer Institute   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Appropriateness criteria; breast conservation therapy; breast radiation; consensus guideline; early stage breast cancer

Indexed keywords

AGE; BREAST CARCINOMA; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; COLLAGEN DISEASE; CONSENSUS; CONSERVATIVE TREATMENT; EXPERT SYSTEM; FAMILY HISTORY; FOLLOW UP; HUMAN; MEDICAL SOCIETY; PARTIAL MASTECTOMY; PATIENT DECISION MAKING; PATIENT SELECTION; PRACTICE GUIDELINE; PREGNANCY; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 44349157518     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2008.02.026     Document Type: Review

References (55)

1. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Manual (2002), Springer-Verlag, New York, NY American Joint Committee on Cancer
2. Morrow M., White J., Moughan J., et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 19 (2001) 2254-2262
3. Parviz M., Cassel J.B., Kaplan B.J., et al. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. J Surg Oncol 84 (2003) 57-62
4. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
5. Practice guideline for breast conservation therapy in the management of invasive breast carcinoma. Practice Guidelines and Technical Standards (2006), American College of Radiology, Reston, VA 443-468
6. Arriagada R., Le M.G., Rochard F., and Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14 (1996) 1558-1564
7. Blichert-Toft M., Rose C., Andersen J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 19-25
8. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
9. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332 (1995) 907-911
10. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
11. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
12. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996) 1659-1664
13. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
14. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348 (1996) 708-713
15. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351 (2004) 963-970
16. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
17. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17 (1999) 2326-2333
18. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
19. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer: a report of further follow-up (2006) San Antonio Breast Cancer Symposium; Abstract 11.
20. Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
21. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
22. Meric F., Buchholz T.A., Mirza N.Q., et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9 (2002) 543-549
23. Morrow M., Bucci C., and Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 186 (1998) 269-274
24. Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 23 (2005) 1678-1684
25. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
26. Chen A.M., Obedian E., and Haffty B.G. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 7 (2001) 480-491
27. Boice Jr. J.D., Harvey E.B., Blettner M., Stovall M., and Flannery J.T. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326 (1992) 781-785
28. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
29. Storm H.H., Andersson M., Boice Jr. J.D., et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84 (1992) 1245-1250
30. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
31. Haffty B.G., Harrold E., Khan A.J., et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359 (2002) 1471-1477
32. Robson M., Svahn T., McCormick B., et al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer 103 (2005) 44-51
33. Gray R.J., Forstner-Barthell A.W., Pockaj B.A., Schild S.E., and Halyard M.Y. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg 188 (2004) 122-125
34. Mark R.J., Zimmerman R.P., and Greif J.M. Capsular contracture after lumpectomy and radiation therapy in patients who have undergone uncomplicated bilateral augmentation mammoplasty. Radiology 200 (1996) 621-625
35. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
36. Peterson M.E., Schultz D.J., Reynolds C., and Solin L.J. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43 (1999) 1029-1035
37. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
38. Benda R.K., Yasuda G., Sethi A., Gabram S.G., Hinerman R.W., and Mendenhall N.P. Breast boost: are we missing the target?. Cancer 97 (2003) 905-909
39. Poortmans P., Bartelink H., Horiot J.C., et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. Radiother Oncol 72 (2004) 25-33
40. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
41. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
42. Olivotto I.A., Chua B., Elliott E.A., et al. A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. Clin Breast Cancer 4 (2003) 361-363
43. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
44. King T.A., Bolton J.S., Kuske R.R., Fuhrman G.M., Scroggins T.G., and Jiang X.Z. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180 (2000) 299-304
45. Kuske R.R., Winter K., Arthur W., et al. A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: Initial outcomes of RTOG 9517. J Clin Oncol 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 22 (2004) 565
46. Vicini F.A., Kestin L., Chen P., Benitez P., Goldstein N.S., and Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95 (2003) 1205-1210
47. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194 (2007) 456-462
48. Vicini F., Winter K., Straube W., et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63 (2005) 1531-1537
49. Formenti S.C., Volm M., Skinner K.A., et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. J Clin Oncol 21 (2003) 864-870
50. Hanna Y.M., Baglan K.L., Stromberg J.S., Vicini F.A., and A Decker D. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 8 (2002) 149-153
51. Bellon J.R., Come S.E., Gelman R.S., et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 23 (2005) 1934-1940
52. Pierce L.J., Moughan J., White J., Winchester D.P., Owen J., and Wilson J.F. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. Int J Radiat Oncol Biol Phys 62 (2005) 183-192
53. Pierce L.J., Hutchins L.F., Green S.R., et al. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol 23 (2005) 24-29
54. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 (2005) 1673-1684
55. Wolmark N., Wang J., Mamounas E., Bryant J., and Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 96-102